Kiniksa Pharmaceuticals, Ltd. (KNSA)

Kiniksa Pharmaceuticals Market Cap

Kiniksa Pharmaceuticals has a market cap or net worth of $1.37 billion as of May 1, 2024. Its market cap has increased by 70.18% in one year.

• Market Cap: 1.37B
• Enterprise Value: 1.17B
• 1-Year Change: 70.18%
• Ranking: #2229
• Category: Small-Cap
• Stock Price: $19.40

Market Cap Chart

Since May 24, 2018, Kiniksa Pharmaceuticals's market cap has increased from $914.40M to $1.37B, an increase of 49.82%. That is a compound annual growth rate of 7.04%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2024	1.33B	0.92%
Apr 29, 2024	1.32B	3.74%
Apr 26, 2024	1.27B	1.53%
Apr 25, 2024	1.25B	-0.94%
Apr 24, 2024	1.26B	1.02%
Apr 23, 2024	1.25B	3.42%
Apr 22, 2024	1.21B	1.10%
Apr 19, 2024	1.19B	0.18%
Apr 18, 2024	1.19B	-0.41%
Apr 17, 2024	1.20B	-2.92%
Apr 16, 2024	1.23B	0.11%
Apr 15, 2024	1.23B	0.87%
Apr 12, 2024	1.22B	-2.32%
Apr 11, 2024	1.25B	1.44%
Apr 10, 2024	1.23B	-1.58%
Apr 9, 2024	1.25B	0.28%
Apr 8, 2024	1.25B	-1.23%
Apr 5, 2024	1.26B	-0.89%
Apr 4, 2024	1.28B	-0.99%
Apr 3, 2024	1.29B	-2.62%
Apr 2, 2024	1.32B	-4.92%
Apr 1, 2024	1.39B	-0.15%
Mar 28, 2024	1.39B	-1.30%
Mar 27, 2024	1.41B	0.10%
Mar 26, 2024	1.41B	0.05%

View and export this data all the way back to 2018. Sign Up Today.

Related Stocks

Company	Market Cap
Establishment Labs Holdings	1.32B
Brookdale Senior Living	1.32B
Day One Biopharmaceuticals	1.30B
Omnicell	1.28B
Soleno Therapeutics	1.27B
Pharvaris	1.26B
Ligand Pharmaceuticals	1.25B
Xencor	1.23B